PLoS ONE (Jan 2017)

Coronary artery disease-associated genetic variants and biomarkers of inflammation.

  • Morten Krogh Christiansen,
  • Sanne Bøjet Larsen,
  • Mette Nyegaard,
  • Søs Neergaard-Petersen,
  • Ramzi Ajjan,
  • Morten Würtz,
  • Erik Lerkevang Grove,
  • Anne-Mette Hvas,
  • Henrik Kjærulf Jensen,
  • Steen Dalby Kristensen

DOI
https://doi.org/10.1371/journal.pone.0180365
Journal volume & issue
Vol. 12, no. 7
p. e0180365

Abstract

Read online

Genetic constitution and inflammation both contribute to development of coronary artery disease (CAD). Several CAD-associated single-nucleotide polymorphisms (SNPs) have recently been identified, but their functions are largely unknown. We investigated the associations between CAD-associated SNPs and five CAD-related inflammatory biomarkers.We genotyped 45 CAD-associated SNPs in 701 stable CAD patients in whom levels of high-sensitivity C-reactive protein (hsRCP), interleukin-6, calprotectin, fibrinogen and complement component 3 levels had previously been measured. A genetic risk score was calculated to assess the combined risk associated with all the genetic variants. A multiple linear regression model was used to assess associations between the genetic risk score, single SNPs, and the five inflammatory biomarkers.The minor allele (G) (CAD risk allele) of rs2075650 (TOMM40/APOE) was associated with lower levels of high-sensitivity C-reactive protein (effect per risk allele: -0.37 mg/l [95%CI -0.56 to -0.18 mg/l]). The inflammatory markers tested showed no association with the remaining 44 SNPs or with the genetic risk score.In stable CAD patients, the risk allele of a common CAD-associated marker at the TOMM40/APOE locus was associated with lower hsCRP levels. No other genetic variants or the combined effect of all variants were associated with the five inflammatory biomarkers.